logo

For the Inventor, By the Inventor

Beijing, China

Xiao-Li Tian

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Cleveland Clinic Foundation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao-Li Tian. Retrieved from https://idiyas.com/inventor/xiao-li-tian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 1,074 
 
The Cleveland Clinic Foundation
 patents

Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents
1. 8207315 - Gene and protein associated with angiogenesis and endothelial cell-specific apoptosis (2012-06-26),

Title: Innovations of Inventor Xiao-Li Tian

Introduction

Xiao-Li Tian is a prominent inventor based in Beijing, China. She has made significant contributions to the field of angiogenesis and endothelial cell biology. Her work focuses on the development of novel therapeutic approaches for diseases related to angiogenesis.

Latest Patents

Xiao-Li Tian holds a patent for a groundbreaking invention titled "Gene and protein associated with angiogenesis and endothelial cell-specific apoptosis." This invention provides isolated nucleic acid and amino acid sequences encoding VG5Q, a novel angiogenic growth factor protein with pro-angiogenic activity. The patent details the protein's unique characteristics, including its subcellular localization during tubulogenesis and its expression in endothelial cells. The invention also outlines methods for using VG5Q in the diagnosis and treatment of angiogenesis-mediated diseases or disorders.

Career Highlights

Xiao-Li Tian is affiliated with the Cleveland Clinic Foundation, where she continues her research and innovation in the field of angiogenesis. Her work has garnered attention for its potential applications in medical science and therapeutic development.

Collaborations

Throughout her career, Xiao-Li Tian has collaborated with esteemed colleagues, including Qing K Wang and Rajkumar Kadaba. These collaborations have further enhanced her research and contributed to advancements in the understanding of angiogenesis.

Conclusion

Xiao-Li Tian's innovative work in the field of angiogenesis exemplifies the impact of scientific research on medical advancements. Her contributions continue to pave the way for new therapeutic strategies in treating angiogenesis-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…